Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 May;8(5):1932-9.
doi: 10.1128/mcb.8.5.1932-1939.1988.

Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line

Affiliations

Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line

D M Zaller et al. Mol Cell Biol. 1988 May.

Abstract

The tissue-specific expression of immunoglobulin genes can be partially explained by a requirement for activating factors found only in B lymphocytes and their derivatives. However, loss of immunoglobulin expression upon fusion of an immunoglobulin-producing myeloma cell with a T lymphoma cell (BW5147) or fibroblast (L cell) suggests that negatively acting factors also play a role in the tissue specificity of immunoglobulin genes. Expression of a cloned immunoglobulin heavy-chain gene introduced into myeloma cells was suppressed after fusion of the myeloma transformants with BW5147. The presence of either the immunoglobulin heavy-chain enhancer or promoter conferred suppression, under similar conditions, upon a heterologous gene that is normally expressed in both B and T lymphocytes. These immunoglobulin heavy-chain gene control regions, or gene modifications induced by them, are subject to negative control by T-lymphocyte-derived factors.

PubMed Disclaimer

References

    1. EMBO J. 1983;2(8):1373-8 - PubMed
    1. Science. 1985 Jan 11;227(4683):134-40 - PubMed
    1. Nature. 1970 Dec 12;228(5276):1086-7 - PubMed
    1. Nat New Biol. 1971 May 19;231(20):87-90 - PubMed
    1. J Natl Cancer Inst. 1974 Feb;52(2):429-36 - PubMed

Publication types

Substances